Oral Micronized Progesterone Manufacturer Copay Program: How to Cut Your Cost in 2026

What Is Oral Micronized Progesterone and Why Does Cost Matter?

Oral micronized progesterone is body-identical progesterone, the same molecular structure the ovaries produce, ground into microscopic particles so fat-soluble absorption is possible in an oral capsule. Brand-name Prometrium received FDA approval in 1998 [1] and remains the reference product against which generics are measured.

Cost matters because progesterone is typically prescribed long-term, often for years, as part of menopausal hormone therapy or luteal-phase support. A prescription that runs $120 per month without assistance adds up to $1,440 per year out of pocket. For many patients, that figure alone drives non-adherence.

Why Progesterone Pricing Is More Complicated Than It Looks

Several overlapping markets set the price a patient actually pays.

Brand vs. Generic. Generic oral micronized progesterone capsules entered the U.S. Market after patent expiration and now dominate dispensing volume. The generic cash-pay average sits near $25, $45 for a 30-day supply, versus $90, $140 or more for brand Prometrium without a savings card.

Compounded vs. FDA-approved. Licensed 503A compounding pharmacies can prepare custom-dose progesterone, typically running $20, $30 per month. The FDA notes that compounded drugs are not FDA-approved and lack the same manufacturing quality oversight as commercial products [2], so the clinical decision should involve your prescriber.

Insurance tier placement. Where a plan places progesterone on its formulary determines whether you pay a $10 generic copay or a $60 brand copay. Formularies differ by plan year, so the tier you paid last year may have changed.

Who Uses Oral Micronized Progesterone?

The 2022 Menopause Society (formerly NAMS) position statement on hormone therapy endorses progestogen use in women with a uterus who take systemic estrogen, to protect the endometrium [3]. Oral micronized progesterone is also used off-label for luteal-phase support in assisted reproduction and for sleep in perimenopausal women, based on progesterone's effect on GABA-A receptors [4].

Because progesterone is prescribed across multiple indications and age groups, the population seeking cost-reduction strategies is broad. A 50-year-old on menopausal HRT and a 34-year-old in an IVF cycle face the same pharmacy counter but may qualify for different savings programs.

Does Prometrium Have a Manufacturer Copay Card?

AbbVie, which now owns Prometrium after acquiring Solvay's pharmaceutical assets, periodically offers patient savings programs. Whether a card is currently active and what it covers changes on a rolling basis. Programs are typically restricted to commercially insured patients and exclude Medicare, Medicaid, and other federal health program beneficiaries.

The framework below helps you identify which savings pathway applies to your situation before calling a pharmacy or visiting a manufacturer website.

How Manufacturer Copay Cards Generally Work

A manufacturer copay card (sometimes called a savings card or coupon card) is a secondary payer. You run your insurance first, then the card pays part or all of your remaining copay up to a monthly or annual cap. Common caps in 2025 to 2026 for brand hormonal drugs run $50, $150 per month in savings.

Key restrictions to expect:

• Commercial insurance required. Nearly every brand manufacturer copay card is explicitly void for patients whose primary coverage is Medicare Part D, Medicaid, TRICARE, or any other government-funded plan. This is not a loophole-able rule. It is written into card terms to comply with federal anti-kickback statutes.
• Pharmacy network limits. Some cards work only at retail chains and not at mail-order or specialty pharmacies.
• Annual cap exhaustion. If your annual cap is $1,200 and your copay is $90 per month, the card covers about 13 months of fills, then stops mid-year.

How to Check Whether an AbbVie Prometrium Card Is Currently Available

Because programs change frequently, the most reliable path is to go directly to AbbVie's myAbbVie Assist portal (abbvie.com/patients) or call 1-800-222-6885. Do not rely on third-party coupon aggregators for brand manufacturer card status; they are often months out of date.

If you find a card is currently available, bring the card's BIN, PCN, and Group numbers to the pharmacy counter, your pharmacist enters these exactly as a secondary insurance claim.

AbbVie Patient Assistance Program (for Uninsured or Underinsured Patients)

Separate from a copay card, AbbVie's myAbbVie Assist program provides free or deeply discounted brand medications to patients who meet income eligibility thresholds and have no insurance or inadequate coverage. Income limits and documentation requirements change annually. The program requires a prescriber's participation (the prescriber submits an enrollment form).

This is worth pursuing if your household income is at or below 400% of the federal poverty level and you have no commercial insurance covering Prometrium.

Generic Oral Micronized Progesterone: The Fastest Route to Lower Cost

For most patients without drug coverage, the generic is the most direct solution. Several manufacturers produce FDA-approved generic micronized progesterone capsules, and competition among them keeps prices low.

Current Generic Cash Prices

Prices vary by pharmacy and fluctuate with wholesaler contracts. Representative 2026 cash-pay estimates for 30 capsules of 200 mg generic oral micronized progesterone:

| Pharmacy | Estimated Cash Price (30 x 200 mg) | |---|---| | Costco (member) | $18, $28 | | Mark Cuban Cost Plus Drugs | $15, $35 | | Walmart Pharmacy | $25, $45 | | CVS / Walgreens (no coupon) | $60, $90 | | CVS / Walgreens (with GoodRx) | $25, $50 |

These are estimates. Always check the current price at your specific pharmacy before filling.

The GoodRx free discount card and similar programs (RxSaver, NeedyMeds, Cost Plus Drugs) are not manufacturer programs but function similarly at the register. They negotiate rebates with pharmacy benefit managers and pass part of the savings to the patient.

Asking for the Generic Specifically

Your prescriber may write "Prometrium" by brand on the prescription. Unless "dispense as written" (DAW) is noted, the pharmacist can substitute an AB-rated generic. Tell your pharmacist explicitly that you want the generic and want the cash price with any applicable coupon applied. Running the transaction through your insurance first and then applying a GoodRx coupon does not work simultaneously, you must choose one.

Insurance Coverage for Oral Micronized Progesterone

Commercial Insurance

Most commercial plans cover oral micronized progesterone because it has established clinical use in menopausal HRT and is recommended by the Menopause Society [3]. The generic typically lands on Tier 1 or Tier 2, meaning a $10, $35 copay. Brand Prometrium usually sits on Tier 3 ($45, $90 copay) or requires a prior authorization.

If your plan places the drug on Tier 3 or higher, you can request a formulary exception or tier exception through your plan's member services. Your prescriber needs to document medical necessity, which is straightforward for menopausal HRT because the Menopause Society's 2022 position statement provides explicit guideline support [3].

Medicare Part D

Medicare Part D covers oral micronized progesterone in most plan formularies when prescribed for an approved indication. The 2025 Medicare redesign capped out-of-pocket drug costs at $2,000 annually [5], which changes the math for patients who previously faced high Tier 3 costs. Check your plan's formulary at Medicare.gov or call 1-800-MEDICARE.

Because manufacturer copay cards cannot be used with Part D, Medicare patients should compare:

1. Their Part D plan's negotiated price after the new $2,000 cap
2. The cash price at Cost Plus Drugs or Costco if they are still in the deductible phase early in the benefit year

Medicaid

Medicaid covers progesterone in most states, though prior authorization policies differ by state. Contact your state Medicaid office or managed-care plan directly to confirm formulary placement and any step-therapy requirements.

Compounded Progesterone: Lower Cost With Different Trade-Offs

Licensed 503A compounding pharmacies can prepare oral micronized progesterone capsules at custom doses for approximately $20, $30 per month, making compounded progesterone one of the lowest-cost options available. Some telehealth and HRT-focused platforms include compounded progesterone in bundled subscription pricing.

The FDA's position is explicit: compounded drugs "are not FDA-approved," meaning they have not undergone the agency's formal review for safety, efficacy, and manufacturing quality [2]. The Menopause Society similarly notes that compounded hormones should not be assumed equivalent to FDA-approved products and that patients choosing compounded products should do so with informed, documented counseling from their prescriber [6].

That does not mean compounded progesterone is unsafe. Licensed compounding pharmacies that comply with USP Chapter 795 standards undergo state board inspection. The risk is variable quality control rather than guaranteed harm. Discuss the trade-off with your prescriber, particularly if you are relying on progesterone for endometrial protection.

Step-by-Step: How to Pay the Least for Oral Micronized Progesterone in 2026

This section consolidates every pathway into a decision sequence so you can identify your lowest-cost route without calling five different phone numbers.

Step 1: Know Your Insurance Status

• Commercial insurance: Check your formulary online or call member services. Get the Tier and copay for generic micronized progesterone 100 mg or 200 mg.
• Medicare Part D: Look up the drug on Medicare.gov Plan Finder under your specific plan.
• Medicaid: Call your managed-care plan or state pharmacy hotline.
• No insurance: Skip to Step 3.

Step 2: If Insured, Evaluate Whether a Copay Card Helps

If your commercial plan covers brand Prometrium but your copay is $80+ per month, check AbbVie's current copay card availability at abbvie.com/patients. If the generic is covered at $15, $35 per month, a copay card likely adds no value.

Medicare and Medicaid patients: copay cards cannot be used. Move to Step 3 or Step 4.

Step 3: Compare Cash Prices With Discount Programs

Run the generic 200 mg, 30-capsule cash price through:

• GoodRx.com (free, no sign-up required for basic prices)
• Mark Cuban Cost Plus Drugs (costplusdrugs.com)
• NeedyMeds.org for additional coupons
• Your local Costco pharmacy (membership not required for pharmacy services in most states)

Pick the lowest price. Many patients find this beats their insurance copay entirely, particularly those in high-deductible health plans early in the benefit year.

Step 4: Consider a Patient Assistance Program

If you are uninsured and your income may qualify, apply to:

• AbbVie myAbbVie Assist (for Prometrium): abbvie.com/patients, 1-800-222-6885
• NeedyMeds.org database of disease-specific and income-based programs
• RxAssist.org directory of pharmaceutical manufacturer programs

Step 5: Discuss Compounded Progesterone With Your Prescriber

If cost remains a barrier after Steps 1 to 4, ask your prescriber whether a 503A compounding pharmacy is appropriate for your clinical situation. At $20, $30 per month, compounded progesterone may resolve affordability completely, with the informed trade-offs documented in your chart.

Clinical Context: Why Progesterone Adherence Has Real Health Consequences

Skipping progesterone doses to save money carries measurable clinical risk for women on systemic estrogen therapy with an intact uterus. Unopposed estrogen increases endometrial cancer risk. The Million Women Study, which followed 1.1 million women in the United Kingdom, found that women on combined estrogen-progestogen therapy had a lower endometrial cancer risk than those on estrogen alone [7].

The Menopause Society's 2022 statement puts the recommendation directly: "In women with a uterus, a progestogen must be added to systemic estrogen to prevent endometrial hyperplasia and cancer" [3]. Cost-driven non-adherence to progesterone is not a neutral financial decision. It is a clinical risk that your prescriber should help you solve with the access strategies above.

Progesterone also influences sleep architecture. A 2018 randomized trial published in Menopause (N=189) found that oral micronized progesterone at 300 mg significantly improved sleep quality scores versus placebo (P<0.001) over 12 weeks [8]. Patients who discontinue for cost reasons may lose both endometrial protection and sleep benefit simultaneously.

The FDA's 1998 approval of Prometrium was based on clinical data showing effective endometrial protection at 200 mg daily for 12 days per cycle or continuous 100 mg daily in combination HRT regimens [1]. Those dose ranges are what generic manufacturers must match for bioequivalence.

What Clinicians Say About Progesterone Access

The Menopause Society 2022 Hormone Therapy Position Statement states: "Micronized progesterone is preferred over synthetic progestogens because of its favorable metabolic and breast safety profile and because it does not appear to attenuate the cardioprotective effects of estrogen" [3].

Endocrine Society clinical practice guidelines on menopause management similarly identify body-identical micronized progesterone as a first-line progestogen choice, citing its tolerability advantage over medroxyprogesterone acetate demonstrated in the PEPI trial [9].

These guideline endorsements mean that when you request a tier exception from your insurer, you have two major professional society guidelines supporting the medical necessity of this specific drug class. That documentation strengthens any prior authorization appeal.